选择语言

ActiveMax® Human BCMA μBeads, premium grade (for cells)
DMF

用户评价
货号-规格
价格
Qty.
合计0件 产品金额0

产品详情

  • Product
    Size
    Amount
    ActiveMax® Human BCMA μBeads, premium grade (for cells)
    2.5 mg
    2.5×10⁷ beads
    ActiveMax® Human BCMA μBeads, premium grade (for cells)
    10 mg (2.5 mg×4)
    1.0×10⁸ beads
  • 产品描述(Product Description)

    ActiveMax® Human BCMA μBeads, premium grade (for cells) are uniform, superparamagnetic beads of 5.5 µm in diameter immobilized with Human BCMA protein expressed from human 293 cells (HEK293) and contains AA Met 1 - Ala 54 (Accession # Q02223-1).
    ActiveMax® Human BCMA μBeads, premium grade (for cells) are produced under sterile manufacturing conditions (ISO 5), and no animal- or human-derived components are used throughout the production process. It is produced under our rigorous quality control system that includes a comprehensive set of tests including sterility and endotoxin tests.

  • 应用说明(Application)

    ActiveMax® Human BCMA μBeads, premium grade (for cells) are designed to stimulate in vitro BCMA-specific CAR-T cells or UCAR-T cells, similar to the tumor cell lines that express human BCMA antigen. It can be used as follows:
    Evaluating the characteristics of CAR-T cells or UCAR-T cells.
    In vitro expansion of BCMA-specific CAR-T cells or UCAR-T cells.
    In vitro enrichment of BCMA-specific CAR-T cells or UCAR-T cells.

  • 重构方法(Reconstitution)

    See Certificate of Analysis (CoA) for detailed instruction.

  • 存储(Storage)

    This product is stable in storage under the following conditions: -20˚C for 12 months in lyophilized state. -70°C for 3 months under sterile conditions after reconstitution.

    Please avoid repeated freeze-thaw cycles after reconstitution. Immediate use after reconstitution is highly recommended.

  • 无菌(Sterility)

    Negative

  • 内毒素(Endotoxin)

    Less than 0.002 EU per μg by the LAL method / rFC method.

  • 注意事项(Important Note)

    This product is for research use only and not intended for therapeutic or in vivo diagnostic use.

  • 制剂(Formulation)

    Please contact us for detailed information.

    Contact us for customized product form or formulation.

  • 质量管理控制体系(QMS)

    1. 质量管理体系(ISO, GMP)
    2. 质量优势
    3. 质控流程

推荐产品

数据展示

  • 流式数据 -FACS Data

     BCMA FACS

    Assay of human BCMA protein on the μBeads surface by Flow cytomtry. The human BCMA conjugated on the μBeads (Cat. No. MBS-C004) surface were fluorescently stained using PE labeled anti-human BCMA antibody and analyzed by flow cytometry.

    Protocol
  • 批间一致性(Batch Consistency)

     BCMA STABILITY

    Add 100ul of 1:40 PE anti-human BCMA Antibody dilution (2.5ul stock solution in 100ul FACS buffer) into 5e5 of ActiveMax® human BCMA μBeads, premium grade (for cells) (Cat. No. MBS-C004), negative control beads (ActiveMax® Streptavidin μBeads, premium grade (for cells) (Cat. No. MBS-C009)) as well. PE signals was used to evaluate BCMA beads binding activity.

  • 稳定性(Stability)

     BCMA STABILITY

    Add 100ul of 1:40 PE anti-human BCMA Antibody dilution (5ul stock solution in 100ul FACS buffer) into 5e5 of ActiveMax® human BCMA μBeads, premium grade (for cells) (Cat. No. MBS-C004), Negative control (ActiveMax® Streptavidin μBeads, premium grade (for cells) (Cat. No. MBS-C009)) as well. PE signals was used to evaluate BCMA beads binding activity.

应用数据(Application Data)
  • 刺激BCMA CAR-T细胞 -Cytokines

     BCMA CYTOKINES

    ActiveMax® Human BCMA μBeads, premium grade (for cells) (Cat.No.MBS-C004) can activate BCMA-specific CAR-T cells by detecting the secretion of IFN- γ in vitro.

     BCMA CYTOKINES

    BCMA CAR-T cells were stimulated with ActiveMax® Human BCMA μBeads (MBS-C004) for 24 h , and cell-free supernatants were harvested for evaluating IFN-γ、TNF-α、IL-4、IL-6 secretion by flow cytomtry. The results showed that BCMA CAR-T cells released significantly larger amounts of IFN-γ、TNF-α、IL-4、IL-6 into the supernatants in response to BCMA μBeads.

  • 刺激BCMA CAR-T细胞 -Cytotoxic Molecules

     BCMA CYTOTOXIC MOLECULES

    BCMA CAR-T cells were stimulated with ActiveMax® Human BCMA μBeads (MBS-C004) for 24h, and cell-free supernatants were harvested for evaluating Granzyme B, Perforin secretion by ELISA. The results showed that BCMA CAR-T cells released significantly larger amounts of Granzyme B, Perforin into the supernatants in response to BCMA μBeads.

用户评价
发表评论

前沿进展

 
药物研发进展
  • 英文全称:

    B-cell maturation protein

  • 中文全称:

    B细胞成熟蛋白

  • 种类:

  • 上市药物数量:

    7 详情

  • 临床药物数量:

    117 详情

  • 最高研发阶段:

    临床三期

联系我们
项目合作
查看更多项目
实验案例分析
查看更多案例分析
  • 产品基础信息
  • 产品详情
  • 推荐产品
  • 数据展示
  • 用户评价